Abeona Selling And Marketing Expenses vs Total Other Income Expense Net Analysis

ABEO Stock  USD 3.26  0.07  2.19%   
Abeona Therapeutics financial indicator trend analysis is way more than just evaluating Abeona Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Abeona Therapeutics is a good investment. Please check the relationship between Abeona Therapeutics Selling And Marketing Expenses and its Total Other Income Expense Net accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.

Selling And Marketing Expenses vs Total Other Income Expense Net

Selling And Marketing Expenses vs Total Other Income Expense Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Abeona Therapeutics Selling And Marketing Expenses account and Total Other Income Expense Net. At this time, the significance of the direction appears to have no relationship.
The correlation between Abeona Therapeutics' Selling And Marketing Expenses and Total Other Income Expense Net is 0.03. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Total Other Income Expense Net in the same time period over historical financial statements of Abeona Therapeutics, assuming nothing else is changed. The correlation between historical values of Abeona Therapeutics' Selling And Marketing Expenses and Total Other Income Expense Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Abeona Therapeutics are associated (or correlated) with its Total Other Income Expense Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Other Income Expense Net has no effect on the direction of Selling And Marketing Expenses i.e., Abeona Therapeutics' Selling And Marketing Expenses and Total Other Income Expense Net go up and down completely randomly.

Correlation Coefficient

0.03
Relationship DirectionPositive 
Relationship StrengthInsignificant

Selling And Marketing Expenses

Total Other Income Expense Net

Most indicators from Abeona Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Abeona Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.As of the 27th of April 2024, Issuance Of Capital Stock is likely to grow to about 45 M, while Selling General Administrative is likely to drop about 18.1 M.

Abeona Therapeutics fundamental ratios Correlations

0.680.570.650.98-0.66-0.310.70.760.97-0.190.34-0.03-0.1-0.40.540.430.390.970.480.570.930.70.420.480.7
0.68-0.040.120.73-0.48-0.10.620.560.69-0.140.05-0.06-0.08-0.310.340.30.030.690.170.080.590.210.010.770.47
0.57-0.040.950.46-0.25-0.370.460.290.54-0.050.50.06-0.11-0.210.380.170.60.540.580.750.540.820.62-0.280.28
0.650.120.950.53-0.16-0.40.680.240.58-0.030.480.04-0.04-0.230.50.120.690.590.610.80.670.870.65-0.150.47
0.980.730.460.53-0.75-0.170.630.830.96-0.250.22-0.13-0.22-0.490.50.440.220.950.440.450.90.620.280.570.67
-0.66-0.48-0.25-0.16-0.75-0.01-0.11-0.99-0.740.19-0.030.150.360.36-0.22-0.250.14-0.73-0.22-0.14-0.48-0.28-0.04-0.4-0.27
-0.31-0.1-0.37-0.4-0.17-0.01-0.4-0.06-0.35-0.64-0.92-0.77-0.76-0.48-0.4-0.32-0.84-0.37-0.36-0.69-0.15-0.48-0.860.2-0.01
0.70.620.460.680.63-0.11-0.40.250.60.10.350.00.05-0.320.70.180.530.620.610.640.740.730.490.320.63
0.760.560.290.240.83-0.99-0.060.250.82-0.180.1-0.12-0.3-0.370.320.3-0.040.810.280.230.60.370.120.450.4
0.970.690.540.580.96-0.74-0.350.60.82-0.160.380.03-0.09-0.310.480.430.351.00.420.520.810.640.40.450.54
-0.19-0.14-0.05-0.03-0.250.19-0.640.1-0.18-0.160.630.720.610.460.40.030.43-0.130.370.35-0.290.230.63-0.31-0.28
0.340.050.50.480.22-0.03-0.920.350.10.380.630.780.660.470.420.410.830.410.460.760.180.580.94-0.320.01
-0.03-0.060.060.04-0.130.15-0.770.0-0.120.030.720.780.880.73-0.020.250.680.04-0.050.25-0.190.070.67-0.3-0.17
-0.1-0.08-0.11-0.04-0.220.36-0.760.05-0.3-0.090.610.660.880.81-0.050.090.7-0.08-0.20.21-0.17-0.050.56-0.21-0.03
-0.4-0.31-0.21-0.23-0.490.36-0.48-0.32-0.37-0.310.460.470.730.81-0.36-0.240.43-0.31-0.41-0.04-0.51-0.330.29-0.39-0.36
0.540.340.380.50.5-0.22-0.40.70.320.480.40.42-0.02-0.05-0.360.250.320.530.90.760.50.820.570.080.35
0.430.30.170.120.44-0.25-0.320.180.30.430.030.410.250.09-0.240.250.160.440.260.330.360.290.360.040.22
0.390.030.60.690.220.14-0.840.53-0.040.350.430.830.680.70.430.320.160.360.30.720.350.590.88-0.270.31
0.970.690.540.590.95-0.73-0.370.620.811.0-0.130.410.04-0.08-0.310.530.440.360.460.550.810.660.430.440.54
0.480.170.580.610.44-0.22-0.360.610.280.420.370.46-0.05-0.2-0.410.90.260.30.460.810.450.880.61-0.060.17
0.570.080.750.80.45-0.14-0.690.640.230.520.350.760.250.21-0.040.760.330.720.550.810.530.910.88-0.260.35
0.930.590.540.670.9-0.48-0.150.740.60.81-0.290.18-0.19-0.17-0.510.50.360.350.810.450.530.670.330.50.86
0.70.210.820.870.62-0.28-0.480.730.370.640.230.580.07-0.05-0.330.820.290.590.660.880.910.670.75-0.080.43
0.420.010.620.650.28-0.04-0.860.490.120.40.630.940.670.560.290.570.360.880.430.610.880.330.75-0.360.21
0.480.77-0.28-0.150.57-0.40.20.320.450.45-0.31-0.32-0.3-0.21-0.390.080.04-0.270.44-0.06-0.260.5-0.08-0.360.36
0.70.470.280.470.67-0.27-0.010.630.40.54-0.280.01-0.17-0.03-0.360.350.220.310.540.170.350.860.430.210.36
Click cells to compare fundamentals

Abeona Therapeutics Account Relationship Matchups

Abeona Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets223.4M151.2M79.6M64.2M64.0M49.3M
Short Long Term Debt Total8.0M8.7M9.4M7.6M5.4M7.9M
Other Current Liab32.9M34.9M10.2M4.2M10.6M5.4M
Total Current Liabilities38.7M42.0M16.6M7.8M13.4M9.8M
Total Stockholder Equity178.4M102.6M51.4M26.8M14.8M28.6M
Net Debt(121.3M)(3.9M)(23.6M)(6.6M)(9.4M)(9.9M)
Retained Earnings(486.5M)(570.7M)(655.6M)(695.3M)(749.5M)(712.0M)
Accounts Payable3.8M4.7M4.3M1.8M1.9M2.5M
Cash129.3M12.6M32.9M14.2M14.8M19.9M
Cash And Short Term Investments129.3M95.0M45.0M52.1M52.6M30.8M
Common Stock Total Equity469K479K836K961K1.1M1.2M
Common Stock Shares Outstanding2.0M3.7M3.9M7.9M21.4M22.4M
Liabilities And Stockholders Equity223.4M151.2M79.6M64.2M64.0M49.3M
Non Current Liabilities Total6.3M6.7M11.6M29.7M35.8M37.5M
Other Current Assets3.1M2.7M7.4M424K729K1.1M
Other Stockholder Equity664.1M672.3M705.6M722.0M764.2M802.4M
Total Liab45.0M48.6M28.2M37.5M49.2M51.6M
Total Current Assets132.4M97.7M55.4M53.1M55.7M32.6M
Common Stock836K961K1.5M177K265K417.6K
Property Plant And Equipment Net21.2M18.4M21.7M11.1M8.0M8.4M
Non Current Assets Total91.0M53.5M24.2M11.1M8.3M7.9M
Non Currrent Assets Other1.1M1.1M1.1M43K277.0K361.3K
Property Plant And Equipment Gross21.2M18.4M21.7M11.1M21.0M22.0M
Short Term Debt1.7M2.0M1.8M1.8M998K948.1K
Intangible Assets43.0M36.2M1.5M1.4M1.6M1.5M
Other Assets1.1M1.1M1.1M43K38.7K36.8K
Property Plant Equipment13.2M18.4M21.7M11.1M12.7M13.4M
Other Liab3.1M20M4.0M23.8M27.4M28.8M
Retained Earnings Total Equity(359.8M)(410.2M)(486.5M)(570.7M)(513.6M)(488.0M)
Net Tangible Assets178.4M68.6M50.0M26.8M30.8M29.2M
Capital Surpluse529.4M543.8M664.1M672.3M773.1M518.5M

Pair Trading with Abeona Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abeona Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Abeona Stock

  0.62A Agilent Technologies Financial Report 28th of May 2024 PairCorr
  0.63ELEV Elevation Oncology Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Abeona Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abeona Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abeona Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abeona Therapeutics to buy it.
The correlation of Abeona Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abeona Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abeona Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abeona Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Abeona Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Abeona Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Abeona Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Abeona Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.
Note that the Abeona Therapeutics information on this page should be used as a complementary analysis to other Abeona Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Abeona Stock analysis

When running Abeona Therapeutics' price analysis, check to measure Abeona Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abeona Therapeutics is operating at the current time. Most of Abeona Therapeutics' value examination focuses on studying past and present price action to predict the probability of Abeona Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abeona Therapeutics' price. Additionally, you may evaluate how the addition of Abeona Therapeutics to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Valuation
Check real value of public entities based on technical and fundamental data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Is Abeona Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.53)
Revenue Per Share
0.164
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(2.61)
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.